CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)) Adverse Event: Retinal vein thrombosis
CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)) Adverse Event: Retinal vein thrombosis is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)); Product category: Drug; Primary reaction: Retinal vein thrombosis.
| Primary drug | CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)) |
|---|---|
| Product category | Drug |
| Primary reaction | Retinal vein thrombosis |
| All reactions | Retinal vein thrombosis; Macular oedema; Retinal artery thrombosis; Incorrect drug administration duration |
| Seriousness | Serious |
| Patient outcome | Recovering/Resolving |
| Patient sex | Female |
| All drugs reported | CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)); CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)); RAMIPRIL |
| Reporter country | IT |
| Reporter type | 1 |
| Report date | 20140313 |
| Report ID | 10006346 |
$299/mo
Try FDATracker →